A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets. Review uri icon

Overview

abstract

  • Identifying effective therapeutic targets for Parkinson's disease (PD) is challenging, with no current disease-modifying therapies available. To address this, The Michael J. Fox Foundation for Parkinson's Research launched the Targets to Therapies (T2T) initiative, uniting experts to prioritize and validate promising targets. T2T aims to develop validation strategies, create comprehensive target data profiles, and build tools to support drug development, ultimately accelerating the discovery of new therapies for PD patients.

authors

publication date

  • June 20, 2025

Identity

PubMed Central ID

  • PMC12181325

Scopus Document Identifier

  • 105008654727

Digital Object Identifier (DOI)

  • 10.1038/s41531-025-01039-3

PubMed ID

  • 40541945

Additional Document Info

volume

  • 11

issue

  • 1